[1]
Todorovska, B., Caloska-Ivanova, V., Dimitrova-Genadieva, M., Trajkovska, M., Popova-Jovanovska, R., Grivceva-Stardelova, K., Licoska-Josifovic, F., Andreevski, V., Curakova-Ristovska, E. and Joksimovic, N. 2019. Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus. Open Access Macedonian Journal of Medical Sciences. 7, 10 (May 2019), 1641–1648. DOI:https://doi.org/10.3889/oamjms.2019.459.